These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 32866906)

  • 1. Curcumin inhibits proteasome activity in triple-negative breast cancer cells through regulating p300/miR-142-3p/PSMB5 axis.
    Liu L; Fu Y; Zheng Y; Ma M; Wang C
    Phytomedicine; 2020 Nov; 78():153312. PubMed ID: 32866906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the regulatory role of FBXL19-AS1 in triple-negative breast cancer through the miR-378a-3p/OTUB2 axis.
    Guo C; Zhang M; Jin X; Zhu C; Qian J; Tao M
    Cell Biochem Funct; 2024 Jun; 42(4):e4020. PubMed ID: 38702967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-124-3p.1 promotes cell proliferation through Axin1-dependent Wnt signaling pathway and predicts a poor prognosis of triple-negative breast cancer.
    Yang W; Cui G; Ding M; Yang M; Dai D
    J Clin Lab Anal; 2020 Jul; 34(7):e23266. PubMed ID: 32125723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-25-3p promotes the proliferation of triple negative breast cancer by targeting BTG2.
    Chen H; Pan H; Qian Y; Zhou W; Liu X
    Mol Cancer; 2018 Jan; 17(1):4. PubMed ID: 29310680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-331-3p Suppresses Cell Proliferation in TNBC Cells by Downregulating NRP2.
    Zhao M; Zhang M; Tao Z; Cao J; Wang L; Hu X
    Technol Cancer Res Treat; 2020; 19():1533033820905824. PubMed ID: 32174262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSMB5 is associated with proliferation and drug resistance in triple-negative breast cancer.
    Wei W; Zou Y; Jiang Q; Zhou Z; Ding H; Yan L; Yang S
    Int J Biol Markers; 2018 Jan; 33(1):102-108. PubMed ID: 28623645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Curcumol enhances the sensitivity of doxorubicin in triple-negative breast cancer via regulating the miR-181b-2-3p-ABCC3 axis.
    Zeng C; Fan D; Xu Y; Li X; Yuan J; Yang Q; Zhou X; Lu J; Zhang C; Han J; Gu J; Gao Y; Sun L; Wang S
    Biochem Pharmacol; 2020 Apr; 174():113795. PubMed ID: 31926937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-508-3p inhibits cell invasion and epithelial-mesenchymal transition by targeting ZEB1 in triple-negative breast cancer.
    Guo SJ; Zeng HX; Huang P; Wang S; Xie CH; Li SJ
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6379-6385. PubMed ID: 30338806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-629-3p may serve as a novel biomarker and potential therapeutic target for lung metastases of triple-negative breast cancer.
    Wang J; Song C; Tang H; Zhang C; Tang J; Li X; Chen B; Xie X
    Breast Cancer Res; 2017 Jun; 19(1):72. PubMed ID: 28629464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-5590-3p-YY1 feedback loop promotes the proliferation and migration of triple-negative breast cancer cells.
    Liang F; Fu X; Wang L
    J Cell Biochem; 2019 Oct; 120(10):18415-18424. PubMed ID: 31190375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.
    Liu X; Tang H; Chen J; Song C; Yang L; Liu P; Wang N; Xie X; Lin X; Xie X
    Oncotarget; 2015 Aug; 6(24):20070-83. PubMed ID: 26036638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-455-3p promotes invasion and migration in triple negative breast cancer by targeting tumor suppressor EI24.
    Li Z; Meng Q; Pan A; Wu X; Cui J; Wang Y; Li L
    Oncotarget; 2017 Mar; 8(12):19455-19466. PubMed ID: 28038450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA-HAGLR motivates triple negative breast cancer progression by regulation of WNT2 via sponging miR-335-3p.
    Jin L; Luo C; Wu X; Li M; Wu S; Feng Y
    Aging (Albany NY); 2021 Aug; 13(15):19306-19316. PubMed ID: 34375306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulating GRP78 reverses pirarubicin resistance of triple negative breast cancer by miR-495-3p mimics and involves the p-AKT/mTOR pathway.
    Liu M; Yang J; Lv W; Wang S; Du T; Zhang K; Wu Y; Feng X
    Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34935899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA Linc00339 promotes triple-negative breast cancer progression through miR-377-3p/HOXC6 signaling pathway.
    Wang X; Chen T; Zhang Y; Zhang N; Li C; Li Y; Liu Y; Zhang H; Zhao W; Chen B; Wang L; Yang Q
    J Cell Physiol; 2019 Aug; 234(8):13303-13317. PubMed ID: 30618083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LINC01096 knockdown inhibits progression of triple-negative breast cancer by increasing miR-3130-3p.
    Wang GP; Mou ZL; Xu YY; Liu GX; Wang DM; Zhang HP
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7445-7456. PubMed ID: 31539132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dihydrotestosterone Induces Chemo-Resistance of Triple-Negative Breast MDA-MB-231 Cancer Cells Towards Doxorubicin Independent of ABCG2 and miR-328-3p.
    Al-Momany B; Hammad H; Ahram M
    Curr Mol Pharmacol; 2021; 14(5):860-870. PubMed ID: 34061013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B; Majid S; Ursu S; de Semir D; Nosrati M; Bezrookove V; Kashani-Sabet M; Dar AA
    Oncotarget; 2016 Apr; 7(15):19519-30. PubMed ID: 26799586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance and mechanism of STAT3/miR-221-3p/Fascin-1 axis in EGFR TKI resistance of triple-negative breast cancer.
    Jin LL; Lu HJ; Shao JK; Wang Y; Lu SP; Huang BF; Hu GN; Jin HC; Wang CQ
    Mol Cell Biochem; 2024 Nov; 479(11):3037-3047. PubMed ID: 38145448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WBP2 Downregulation Inhibits Proliferation by Blocking YAP Transcription and the EGFR/PI3K/Akt Signaling Pathway in Triple Negative Breast Cancer.
    Song H; Wu T; Xie D; Li D; Hua K; Hu J; Fang L
    Cell Physiol Biochem; 2018; 48(5):1968-1982. PubMed ID: 30092563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.